AR cooperates with SMAD4 to maintain skeletal muscle homeostasis.
Journal article
Forouhan M. et al, (2022), Acta Neuropathol
Impact assessments of wind farms on seabird populations that overlook existing drivers of demographic change should be treated with caution
Journal article
Horswill C. et al, (2022), Conservation Science and Practice, 4
Proof of concept of peptide-linked blockmiR-induced MBNL functional rescue in myotonic dystrophy type 1 mouse model
Journal article
Overby SJ. et al, (2022), Molecular Therapy - Nucleic Acids, 27, 1146 - 1155
Control of backbone chemistry and chirality boost oligonucleotide splice switching activity.
Journal article
Kandasamy P. et al, (2022), Nucleic Acids Res
Enhancing the Therapeutic Potential of Extracellular Vesicles Using Peptide Technology
Chapter
Martin Perez C. et al, (2022), Methods in Molecular Biology, 2383, 119 - 141
Author Correction: GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain.
Journal article
Dar GH. et al, (2021), Nat Commun, 12
Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy.
Journal article
Cerro-Herreros E. et al, (2021), Mol Ther Nucleic Acids, 26, 174 - 191
GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain.
Journal article
Dar GH. et al, (2021), Nat Commun, 12
RASSF1C oncogene elicits amoeboid invasion, cancer stemness, and extracellular vesicle release via a SRC/Rho axis.
Journal article
Tognoli ML. et al, (2021), EMBO J
Amelioration of systemic inflammation via the display of two different decoy protein receptors on extracellular vesicles.
Journal article
Gupta D. et al, (2021), Nat Biomed Eng, 5, 1084 - 1098
Dystrophin involvement in peripheral circadian SRF signalling
Journal article
Betts CA. et al, (2021), Life Science Alliance, 4, e202101014 - e202101014
Gene therapy with AR isoform 2 rescues spinal and bulbar muscular atrophy phenotype by modulating AR transcriptional activity.
Journal article
Lim WF. et al, (2021), Sci Adv, 7
Combining multiomics and drug perturbation profiles to identify muscle-specific treatments for spinal muscular atrophy.
Journal article
Meijboom KE. et al, (2021), JCI Insight, 6
Mesyl Phosphoramidate Oligonucleotides as Potential Splice Switching Agents: Impact of Backbone Structure on Activity and Intracellular Localization
Journal article
HAMMOND SM. et al, (2021), Nucleic Acid Therapeutics
Extracellular vesicles as a next-generation drug delivery platform
Journal article
WOOD M. et al, (2021), Nature Nanotechnology
Emerging Oligonucleotide Therapeutics for Rare Neuromuscular Diseases.
Journal article
Aoki Y. and Wood MJA., (2021), J Neuromuscul Dis
Improving assessments of data-limited populations using life-history theory
Journal article
Horswill C. et al, (2021), Journal of Applied Ecology, 58, 1225 - 1236
Mesyl Phosphoramidate Oligonucleotides as Potential Splice-Switching Agents: Impact of Backbone Structure on Activity and Intracellular Localization.
Journal article
Hammond SM. et al, (2021), Nucleic Acid Ther
Applications of digital imaging and analysis in seabird monitoring and research
Journal article
Edney AJ. and Wood MJ., (2021), Ibis, 163, 317 - 337
Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy.
Journal article
Winkelsas AM. et al, (2021), Mol Ther Nucleic Acids, 23, 731 - 742